Business Interruption & Loss of Production Insurance

CALL FOR EXPERT ADVICE
GET A QUOTE

Specialist business interruption cover for pharmaceutical and life-sciences manufacturing — protecting cash flow when incidents stop production, delay batch release or disrupt supply.

CALL FOR EXPERT ADVICE
GET A QUOTE

We compare quotes from leading insurers

  • Allianz
  • Aviva
  • QBE
  • RSA
  • Zurich
  • NIG

BUSINESS INTERRUPTION COVER THAT HELPS YOU TAKE OFF

Why Business Interruption Matters in Pharmaceutical Manufacturing

Pharmaceutical manufacturing is defined by time: validated processes, controlled environments, long lead times for specialist parts, strict release testing, and tightly scheduled customer commitments. When an incident stops production — fire, flood, equipment breakdown, contamination investigation, or critical utility failure — the financial impact is often far greater than the physical damage.

Business interruption (BI) insurance is designed to protect your cash flow by covering loss of gross profit (and often extra expense) during the period your business is disrupted. For pharmaceutical and life-sciences sites, the challenge is that “recovery” isn’t simply restarting a machine. You may need to clean and revalidate areas, re-qualify equipment, re-run environmental monitoring, replace destroyed stock, repeat stability or release testing, and satisfy customer audits before shipments resume.

If your policy is not structured around these realities, you can end up underinsured: inadequate indemnity period, missing extensions for key causes of loss, and sums insured that don’t reflect the true time needed to restore output. Insure24 helps manufacturers arrange BI and loss of production cover designed for real manufacturing recovery timelines.

What Is Business Interruption & Loss of Production Insurance?

Business interruption insurance is a financial protection policy designed to replace lost income (typically gross profit) when your business cannot operate normally due to an insured event. In manufacturing, this is often described as “loss of production” because the disruption reduces output, delays shipments, and interrupts contractual supply.

BI is usually linked to a property damage policy (often called “material damage”) — meaning that business interruption is triggered by physical loss or damage to insured property. However, many manufacturers also need extensions to address non-damage events or specialist triggers such as machinery breakdown, utility failure, or denial of access.

For pharmaceutical businesses, the most important BI questions are: (1) what events can trigger BI; (2) how “gross profit” is defined; (3) what extra expenses are covered; and (4) how long the insurer will pay for loss (the indemnity period). Getting these wrong can be more damaging than having no BI at all, because it creates a false sense of security.

  • Loss of gross profit due to reduced turnover/output
  • Fixed costs that continue during downtime (wages, rent, finance)
  • Increased cost of working / extra expense (outsourcing, overtime)
  • Costs to minimise the interruption and speed recovery
  • Often includes “reasonable” mitigation expenses (wording dependent)

Because pharmaceutical recovery can involve revalidation and regulatory scrutiny, the BI section should be designed with realistic restoration timeframes. The correct indemnity period is often 12, 18, 24 or 36 months depending on complexity and supply chain dependencies.

CALL FOR EXPERT ADVICE
GET A QUOTE

What Can Cause Loss of Production in Pharmaceutical Manufacturing?

Loss of production is not always caused by catastrophic events. In many pharmaceutical sites, the most damaging disruptions are caused by “secondary effects”: contamination investigations, control system failures, prolonged lead times for specialist parts, or utility interruptions that compromise validated conditions.

The list below illustrates common triggers. Your insurance programme should be built around the triggers most relevant to your site, not generic assumptions. We help ensure the core property/BI structure is paired with the right extensions for equipment and operational dependencies.

Typical BI Triggers (Property Linked)

  • Fire, smoke or heat damage to production areas
  • Flood, escape of water, sprinkler discharge
  • Storm damage affecting roofs, plant rooms, warehouses
  • Theft or malicious damage impacting equipment or stock
  • Impact damage in warehouses and loading bays

These triggers are common, but pharmaceutical recovery can still take much longer than other industries due to cleaning, validation and batch release complexity.

Operational Triggers Often Overlooked

  • Machinery breakdown (tablet presses, encapsulators, filling lines)
  • HVAC or environmental control failures affecting cleanrooms
  • Utility failure: power, steam, compressed air, purified water, WFI
  • Contamination event leading to shutdown and investigation
  • Supply chain disruption for critical ingredients or packaging
  • Denial of access (e.g., emergency services, nearby incidents)

These triggers may require specific policy sections or endorsements. For example, machinery breakdown cover is often separate to standard property insurance, and utility failure extensions may have time-based deductibles or sub-limits.

CALL FOR EXPERT ADVICE
GET A QUOTE NOW

Why Pharmaceutical BI Claims Are Different

In many industries, a business interruption claim is a straightforward calculation: physical damage occurs, repairs are made, and trading resumes. In pharmaceutical manufacturing, the restoration timeline is often dominated by the steps required to return to a compliant state.

After an incident, you may need to clean and requalify controlled areas, validate environmental controls, recalibrate instruments, re-run cleaning validation, complete deviation investigations, and sometimes satisfy customer or regulator scrutiny before output can resume. These steps add time — and time is the core driver of BI claim size.

This is why selecting an adequate indemnity period and realistic gross profit sum insured is critical. Underestimating the time to restore production is one of the most common BI underinsurance problems in complex manufacturing sectors.

Pharma-Specific Recovery Drivers

  • Cleaning and decontamination requirements
  • Revalidation / requalification (IQ/OQ/PQ) steps
  • Environmental monitoring and trend confirmation
  • Batch release testing and laboratory backlog
  • Long lead times for specialist equipment parts
  • Customer re-audits and quality agreement requirements

These elements should inform your BI assumptions. A policy designed for “generic manufacturing” may not capture the true duration of disruption in a GMP environment.

What BI Should Help You Do

  • Keep paying essential fixed costs during downtime
  • Fund extra expense to maintain supply commitments
  • Support overtime, outsourcing and expedited logistics
  • Protect cash flow while production is restored
  • Give management breathing room to make the right decisions

BI insurance is not just a payout — it’s a stabiliser. It allows you to prioritise safe, compliant recovery rather than rushing decisions that could create further regulatory or customer damage.

CALL FOR EXPERT ADVICE
GET A QUOTE NOW

Choosing the Right Indemnity Period & Sums Insured

The indemnity period is the maximum time the insurer will pay for loss of gross profit following an insured event. Choosing the right period is one of the most important decisions in BI insurance.

In pharmaceutical manufacturing, a 12-month indemnity period can be insufficient if you have long equipment lead times, complex validation requirements, or a single-point-of-failure production line. Many businesses choose 18, 24 or 36 months to reflect realistic recovery scenarios.

Sums insured should reflect your gross profit exposure — and should incorporate growth, seasonality, planned expansions, and the cost structure of your business. Underinsurance can reduce claim payments because BI policies often apply average clauses where sums insured are inadequate.

Indemnity Period: What to Consider

  • Lead times for specialist equipment and parts
  • Time required for cleaning and revalidation
  • Time to rebuild stock and work-in-progress
  • Customer quality re-approval and audits
  • Seasonality and contractual delivery windows

The goal is to select a period that reflects not just “repairs”, but “restored trading capacity”. In regulated manufacturing, those are not the same thing.

Gross Profit: Common Pitfalls

  • Using turnover instead of gross profit definitions
  • Ignoring growth or planned expansion
  • Underestimating the cost of catch-up production
  • Not allowing for increased costs of working
  • Not aligning “standing charges” with real fixed costs

We help you structure the BI basis so it matches your accounts and reflects the way your business actually earns profit — which is essential for smooth claims handling.

CALL FOR EXPERT ADVICE
GET A QUOTE NOW

How BI Insurance Helps Pharmaceutical Manufacturers in Real Incidents

Case Study: Utility Failure Stops Production

Situation: A power issue disrupted environmental controls affecting controlled areas.

Impact: Production was paused while systems were stabilised and quality checks were completed.

Resolution: A well-structured programme combining BI and relevant extensions supported loss of gross profit and mitigation costs during the shutdown period.

Case Study: Equipment Breakdown with Long Lead Parts

Situation: A critical production machine failed and replacement parts had extended lead times.

Impact: Output reduced, deliveries delayed and contractual pressure increased.

Resolution: Machinery breakdown and BI sections responded to repair costs and loss of gross profit, while extra expense supported outsourcing and expedited logistics.

CALL FOR EXPERT ADVICE
GET A QUOTE NOW
Quote icon

“The physical damage was one thing — but the time to revalidate and restart was the real cost. Our business interruption cover helped protect cash flow during recovery.”

Operations Lead, UK GMP Manufacturer

UNIQUE INSURANCE
TAILORED FOR YOU 

PROTECT YOURSELF

  • Loss of gross profit when production is disrupted
  • Extra expense to maintain supply commitments
  • Coverage aligned to GMP recovery and validation timelines
  • Support for mitigation and recovery actions
  • Policy structure designed around operational dependencies

We structure BI and loss of production cover around the realities of regulated manufacturing. That means mapping your critical utilities, identifying single-point equipment dependencies, and selecting an indemnity period that reflects the time needed to return to compliant production — not just “repair the building”.

We can also integrate machinery breakdown, utility failure and other extensions where appropriate, so your programme responds to the causes of interruption that most commonly occur in pharmaceutical environments.

CALL FOR EXPERT ADVICE
GET A QUOTE

FREQUENTLY ASKED QUESTIONS

+-

What does business interruption insurance cover?

Business interruption (BI) insurance typically covers loss of gross profit and may cover increased cost of working/extra expense when your business cannot operate normally due to an insured event. It is often linked to property damage, but policies can include extensions for specific triggers such as machinery breakdown or utility failure.

+-

Why is BI particularly important for pharmaceutical manufacturers?

Pharmaceutical recovery often requires cleaning and revalidation, environmental monitoring, batch release testing, and sometimes customer or regulatory scrutiny. These steps can extend downtime significantly beyond physical repairs, increasing the financial impact of lost production.

+-

How long should the indemnity period be?

The correct indemnity period depends on your operation, equipment lead times, validation requirements, and how quickly you can restore compliant production. Many manufacturers choose 12, 18, 24 or 36 months. The goal is to cover the time needed to restore trading capacity, not just repair physical damage.

+-

Does BI cover equipment breakdown?

Standard BI is often triggered by property damage, and machinery breakdown may require a separate section or policy. Many programmes combine machinery breakdown with BI to ensure downtime caused by equipment failure is covered, subject to the policy wording and conditions.

+-

What is “increased cost of working”?

Increased cost of working (ICOW) or extra expense refers to reasonable additional costs incurred to reduce the interruption and maintain output, such as outsourcing, overtime, expedited freight, temporary equipment hire, or alternative premises. Cover and limits vary by policy.

+-

How do I get a quote for BI and loss of production cover?

Call 0330 127 2333 or request a quote online. We’ll ask about turnover/gross profit, key production lines, critical utilities, equipment dependencies, claims history, and the indemnity period you need. For pharmaceutical risks, we’ll also discuss validation timelines and recovery planning to ensure accurate cover.
CALL FOR EXPERT ADVICE
GET A QUOTE

Related Blogs